Literature DB >> 7967505

Seminomas of the canine testis. Counterpart of spermatocytic seminoma of men?

L H Looijenga1, R A Olie, I van der Gaag, F J van Sluijs, J Matoska, J Ploem-Zaaijer, C Knepflé, J W Oosterhuis.   

Abstract

BACKGROUND: Dogs develop germ cell tumors of the testis at a relatively high rate. It is not known to what degree these tumors resemble various human testicular neoplasms. EXPERIMENTAL
DESIGN: The epidemiology and morphology of a series of spontaneous canine testicular tumors, collected between 1985 and 1991, was analyzed, and compared with human testicular germ cell tumors. DNA content analysis of representative samples was performed using flow cytometry and image cytometry. Eight human spermatocytic seminomas were studied in parallel.
RESULTS: All canine tumors had the histopathologic features reported as typical for dog testis seminomas. These tumors could show both an intratubular and an invasive component. Most of them were pure (78%), while they could be combined with a Leydig cell tumor, a Sertoli cell tumor, or both. No somatic, placental or yolk sac cells were identified, and there was no carcinoma in situ (CIS). A bimodal age distribution, with a peak around 1 year of age and between 4 and 16 years of age, was found for all pure and mixed testicular tumors, except for those composed of a Leydig cell and a seminoma component. These tumors were all present in dogs older than 7 years, being significantly more older (p < 0.01) than dogs with a pure tumor of either type. All Sertoli cell and Leydig cell tumors were diploid. No consistent peritriploid DNA content, characteristic of human testicular germ cell tumors, was found for canine seminomas, which most often had a diploid DNA content. Human spermatocytic seminomas always contained diploid tumor cells, and showed a relatively low number of high ploidy cells, comparable to canine seminomas of the testis.
CONCLUSIONS: The so-called seminomas of the testis are tumors of old age. Histologically, these tumors are composed of a single cell type with some variation without evidence of differentiation. It is proposed that canine seminoma correspond to human spermatocytic seminomas. It is thought that the Leydig elements in these tumors represent a reactive change rather than biphasic differentiation of a single stem cell capable of germinal and sex-cord cell development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7967505

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  6 in total

1.  X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status.

Authors:  L H Looijenga; A J Gillis; R J van Gurp; A J Verkerk; J W Oosterhuis
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 2.  Human spermatogonial stem cells: a possible origin for spermatocytic seminoma.

Authors:  R Waheeb; M-C Hofmann
Journal:  Int J Androl       Date:  2011-08

Review 3.  Molecular mechanisms behind the resistance of cisplatin in germ cell tumours.

Authors:  Josep Ma Piulats; Laura Jiménez; Xavier García del Muro; Alberto Villanueva; Francesc Viñals; José R Germà-Lluch
Journal:  Clin Transl Oncol       Date:  2009-12       Impact factor: 3.405

Review 4.  New insights into the pathology and molecular biology of human germ cell tumors.

Authors:  Friedemann Honecker; J Wolter Oosterhuis; Frank Mayer; Jörg Thomas Hartmann; Carsten Bokemeyer; Leendert H J Looijenga
Journal:  World J Urol       Date:  2004-03-20       Impact factor: 4.226

5.  Morphological and immunohistochemical characterisation of seminomas in Norwegian dogs.

Authors:  Tor Espen Thorvaldsen; Ane Nødtvedt; Tom Grotmol; Gjermund Gunnes
Journal:  Acta Vet Scand       Date:  2012-09-17       Impact factor: 1.695

Review 6.  Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology.

Authors:  Leendert H J Looijenga; Chia-Sui Kao; Muhammad T Idrees
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.